心血管医学中的利益冲突:对胸外科临床实践的启示
该文以心血管医学为范例,分析利益冲突在临床试验多个层面(从研究问题、数据收集与裁定到结果报告及spin现象)的影响,指出行业赞助与非赞助研究均可能受利益冲突影响,结局与复合终点选择也是潜在来源。大型随机对照试验显著影响国际指南及临床实践,因此需批判性评估利益冲突;即使科学学会与指南专家组也未必完全无利益冲突,可能损害其公信力。共享规则、认识利益冲突机制及外部数据访问透明化有助于促进循证研究并减轻利益冲突影响。
要点
- 利益冲突可影响研究问题、数据收集与裁定、结果报告及spin现象等多个层面。
- 结局与复合终点的选择及定义是利益冲突干扰的潜在来源。
- 大型随机对照试验影响指南与临床实践,需批判性评估其利益冲突。
核心结论
- 利益冲突可能通过多种方式影响行业赞助与非赞助研究,需有效管理以重建循证医学的中心地位。
- 有效管理利益冲突应维护公众对心血管专业的信任,同时不损害研究者与行业之间的积极关系。
研究设计与样本
- 原文为心血管医学领域的综述/观点文章,未报告系统检索范围、样本量或研究设计细节。
主要发现
- 利益冲突影响可能始于研究问题、数据收集与裁定,直至结果报告,包括spin现象。
- 结局与终点(尤其是复合终点)的选择和定义也是利益冲突干扰的潜在来源。
- 大型随机对照试验显著影响国际指南并进而影响临床实践,因此对其利益冲突的批判性评估是必须的。
- 尽管有旨在减轻利益冲突影响的特定方案,科学学会与指南专家组也可能并非完全无利益冲突,可能负面影响其问责性与可信度。
关键数值与推荐
- 原文未报告具体推荐等级、强度标签、剂量、给药方案、阈值或定量标准。
临床怎么用
- 原文提出共享规则、认识利益冲突机制及外部数据访问透明化可能有助于促进循证研究并减轻利益冲突影响。
- 原文提出有效管理利益冲突应维护公众信任且不损害研究者与行业的积极关系。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular diseases represent a major burden worldwide, and clinical trials are critical to define treatment improvements. Since various conflicts of interest (COIs) may influence trials at multiple levels, cardiovascular research represents a paradigmatic example to analyze their effects and manage them effectively to re-establish the centrality of evidence-based medicine.Despite the manifest role of industry, COIs may differently affect both sponsored and non-sponsored studies in many ways. COIs influence may start from the research question, data collection and adjudication, up to result reporting, including the spin phenomenon. Outcomes and endpoints (especially composite) choice and definitions also represent potential sources for COIs interference. Since large randomized controlled trials significantly influence international guidelines, thus impacting also clinical practice, their critical assessment for COIs is mandatory. Despite specific protocols aimed to mitigate COI influence, even scientific societies and guideline panels may not be totally free from COIs, negatively affecting their accountability and trustworthiness.Shared rules, awareness of COI mechanisms and transparency with external data access may help promoting evidence-based research and mitigate COIs impact. Managing COIs effectively should preserve public trust in the cardiovascular profession without compromising the positive relationships between investigators and industry.
引用
- Ronco D, Albuquerque AM, Marin-Cuartas M, et al. Conflicts of interest in clinical practice: lessons learned from cardiovascular medicine. Eur J Cardiothorac Surg. 2024. PMID: 39313866. doi:10.1093/ejcts/ezae296
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。